Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nat Genet ; 52(7): 719-727, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32483291

RESUMO

The Mediator complex directs signals from DNA-binding transcription factors to RNA polymerase II (Pol II). Despite this pivotal position, mechanistic understanding of Mediator in human cells remains incomplete. Here we quantified Mediator-controlled Pol II kinetics by coupling rapid subunit degradation with orthogonal experimental readouts. In agreement with a model of condensate-driven transcription initiation, large clusters of hypophosphorylated Pol II rapidly disassembled upon Mediator degradation. This was accompanied by a selective and pronounced disruption of cell-type-specifying transcriptional circuits, whose constituent genes featured exceptionally high rates of Pol II turnover. Notably, the transcriptional output of most other genes was largely unaffected by acute Mediator ablation. Maintenance of transcriptional activity at these genes was linked to an unexpected CDK9-dependent compensatory feedback loop that elevated Pol II pause release rates across the genome. Collectively, our work positions human Mediator as a globally acting coactivator that selectively safeguards the functionality of cell-type-specifying transcriptional networks.


Assuntos
Regulação da Expressão Gênica , Complexo Mediador/fisiologia , Transcrição Gênica , Animais , Linhagem Celular Tumoral , Cromatina/fisiologia , Drosophila , Perfilação da Expressão Gênica , Técnicas de Introdução de Genes , Humanos , Complexo Mediador/genética , Fator B de Elongação Transcricional Positiva/metabolismo , RNA Polimerase II/metabolismo
2.
ACS Chem Biol ; 13(3): 553-560, 2018 03 16.
Artigo em Inglês | MEDLINE | ID: mdl-29356495

RESUMO

Protein degradation is an emerging therapeutic strategy with a unique molecular pharmacology that enables the disruption of all functions associated with a target. This is particularly relevant for proteins depending on molecular scaffolding, such as transcription factors or receptor tyrosine kinases (RTKs). To address tractability of multiple RTKs for chemical degradation by the E3 ligase CUL4-RBX1-DDB1-CRBN (CRL4CRBN), we synthesized a series of phthalimide degraders based on the promiscuous kinase inhibitors sunitinib and PHA665752. While both series failed to induce degradation of their consensus targets, individual molecules displayed pronounced efficacy in leukemia cell lines. Orthogonal target identification supported by molecular docking led us to identify the translation termination factor G1 to S phase transition 1 (GSPT1) as a converging off-target, resulting from inadvertent E3 ligase modulation. This research highlights the importance of monitoring degradation events that are independent of the respective targeting ligand as a unique feature of small-molecule degraders.


Assuntos
Terminação Traducional da Cadeia Peptídica , Fatores de Terminação de Peptídeos , Proteólise , Linhagem Celular Tumoral , Humanos , Simulação de Acoplamento Molecular , Ftalimidas/química , Inibidores de Proteínas Quinases/química , Ubiquitina-Proteína Ligases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...